The disclosed subject matter relates generally to methods and apparatus for monitoring the metabolic state and viability of living tissue or a live cell population, that has been cultured in-vitro using continuous or semi-continuous perfusion of culture media. The disclosed subject matter also relates to methods and apparatus for monitoring oxygen consumption, and key metabolic components of a live cell population, that is captive in one or more cell culture chambers.
Metabolism is the biochemical process in living organisms, where energy, harvested from an organism's environment, is used to synthesize molecules or break down molecules into components needed to sustain life. The relative health and viability of a living organism can be determined by monitoring its metabolic rate. While specific metabolic pathways may vary significantly across organisms, in the animal kingdom, a generally useful key indicator of aerobic metabolism is the consumption of oxygen. Other indicators of metabolic state include the oxidative state of nicotinamide adenine dinucleotide (NAD+, NADH) and of cytochrome-c, key metabolic components performing electron transfer.
The monitoring of oxygen consumption and other metabolic components is important to understanding the basic biology of cell life-cycles and the relative health of a population of cells. There has been significant work attempting to monitor the rate of metabolism of cultured cells.
An example of the importance of metabolic monitoring is in the treatment of diabetes mellitus, such as Type I diabetes. Type I diabetes is such that the body can not control glucose due to loss of beta cells, one of the components of cell clusters known as the Islets of Langerhans (hereinafter, also referred to as “Islets”). These specialized cell clusters are located in the pancreas and regulate physiological blood sugar levels by producing insulin. A transplantation of human Islets from a non-diabetic donor into a diabetic recipient, to treat diabetes was disclosed in, Hatipoglu, et al., “Islets Transplantation: Current Status and Future Directions,” Current Diabetes Reports, Vol. 5, pages 311-316 (2005).
The increasing demand for Islets of Langerhans transplantations has created the need to predict the viability of Islets of Langerhans in-vitro, before transplantation. These predictions are necessary to improve success rates and reduce the costs of this expensive procedure, as discussed in, Ichii, et al., “A Novel Method for the Assessment of Cellular Composition and Beta-Cell Viability in Human Islet Preparations,” American Journal of Transplantation, Vol. 5, pp. 1635-1645 (2005). In-vitro studies require cultures of Islets of Langerhans during extended periods of time, from hours to days. Continuous vertical perfusion (“perfusion” as used herein also known as perfusion and profusion) of oxygenated media improves the outcome of these procedures.
In vertical perfusion, cultured cells are exposed to media that flows upward, or vertically, through the cells. By flowing vertically, mechanical stress on the cells due to the hydrodynamic pressure against the cells is minimized. This pressure against the cells counteracts gravity and serves to suspend the cells, for example, as disclosed in, Sweet, et al., “Continuous Measurement of Oxygen Consumption by Pancreatic Islets,” Diabetes Technology & Therapeutics, Vol. 4, No. 5, pp. 661-672 (2002) (hereinafter “Sweet, et al.”). With continuous perfusion, cell wastes, including excreted compounds, are continually swept away, while nutrients and oxygen are continually renewed.
Accordingly, continuous vertical perfusion is an ideal culture environment, that better simulates in-vivo conditions than static in-vitro culture methods, as it continually replenishes the culture media. This is unlike static culture methods, where cells are suspended in Petri dishes, culture bags, or microtiter plates, with the culture medium not being replenished. Additionally Sweet, et al., disclosed that monitoring of oxygen during a perfusion culture can be used as a prediction of post-transplant viability in animals.
Continuous flow perfusion systems permit measurement of oxygen consumption of cultured cells. For example, the oxygen consumption in the Islets of Langerhans has been continuously monitored based on the assumption of a known amount of oxygen dissolved into media flowing into the perfusion chamber. The known amount was generated by equilibrating the media with a standard gas mixture. The oxygen concentration of the media was measured by the oxygen sensor at the outflow. The assumption made was that the difference between the oxygen concentration in the outflow and the expected value from the standard solution was due only to oxygen consumption of the contained Islets of Langerhans.
Conventional perfusion systems have several operational limitations which limit their utility and ease of use. For example, these conventional perfusion systems are difficult to load with cells while maintaining sterility of the system. This is because, as noted in Sweet, et al., loading cells in to the systems described therein, requires assembly of numerous parts under sterile conditions. Additionally, the chamber disclosed in Sweet, et al. requires multiple steps in the loading process.
Yet another drawback of these conventional perfusion systems is that measurements of cytochrome-c oxidative state via light absorbance are electrically noisy and inaccurate. This is due to the fact that the small number of Islets of Langerhans have a small optical density. While Sweet et al., discloses light scattering beads to improve absorption, the resultant absorbance signal remains weak.
The disclosed subject matter provides systems, methods and devices for the monitoring of the metabolism and the health of cultured cells. The disclosed subject matter includes devices that simplify the loading of cells and enable loading under sterile conditions. The disclosed subject matter includes devices, to culture, measure and monitor the metabolism of a population of cells, and in particular, to accurately measure metabolic states simultaneously in multiple cell populations. By being able to measure and monitor the metabolism of cells, the disclosed subject matter may lead to higher transplantation success rates at lower costs, more efficient qualification of drug candidates prior to animal studies, better management of diabetes mellitus, and improved human health.
In one embodiment, the disclosed subject matter provides a perfusion culture chamber for monitoring the metabolism of cells contained within a defined culture region. The perfusion chamber is formed of two pieces, movable with respect to each other, for loading cells and then returned to the initial position to enclose the cells in the perfusion chambers for perfusion analysis. Each perfusion chamber is within a flow channel, which provides an inflow and outflow for culture media, and is made from oxygen impermeable material. The perfusion chamber has two porous obstructions, plugs or frits, with pores sufficiently small to prevent cells from escaping a culture region of interest within the perfusion chamber, but with porosity sufficiently large that minimal back pressure is generated. An input oxygen sensor measures the amount of oxygen dissolved in the culture media before it reaches the culture region, and an output oxygen sensor measures the amount of oxygen dissolved in the media after leaving the culture region. The difference in dissolved oxygen can be related to the rate of oxygen consumption, provided the media flow rates are known.
Another embodiment of the disclosed subject matter provides a perfusion culture chamber for monitoring the metabolism of cells contained within a defined culture region and constructed for moving the porous obstructions out of the perfusion flow path to facilitate quick and sterile loading of cells into the culture region.
In another embodiment of the disclosed subject matter, there is provided a perfusion culture chamber for monitoring the optical properties, for example, spectral absorbance or fluorescence of compounds related to the metabolism of the cultured cell population.
The disclosed subject matter also provides methods related to the use of the perfusion culture chamber. One method is directed to monitoring the oxygen consumption of the cells in the culture region. Another method measures the oxidative state of cytochrome-c of the cells in the culture region. Yet another method combines the measurement of metabolic indicators to assess the health of a cultured cell population for various purposes, such as prediction of viability when transplanted into a recipient organism, prediction of apoptosis, or the like.
Another embodiment of the disclosed subject matter is directed to an apparatus for analyzing material, for example, cells. The apparatus includes at least a first member and a second member movable, for example, by sliding, with respect to each other. There is at least one perfusion chamber, at least a portion of the at least one perfusion chamber in the first member and at least one portion of the at least one perfusion chamber in the second member. There is also at least one loading channel at least in the first member corresponding to the at least one perfusion chamber, and the first member and the second member movable with respect to each other between at least a first position and a second position. The first position is such that the at least one perfusion chamber is formed by the portions of the at least one perfusion chamber in the first member, and the second member being aligned, to enclose a volume for holding the cells in a sealed and sterile arrangement, free of ambient contaminants. The second position is such that the at least one loading channel is operatively coupled, for example, in alignment, with the portion of the at least one perfusion chamber in the second member.
Another embodiment of the disclosed subject matter is directed to an apparatus for analyzing material. The apparatus includes at least a first member and a second member movable with respect to each other between a first position and a second position, for example, by sliding. There is an inflow port in the second member and a plurality of outflow ports in the first member. There is also a plurality of flow channels, with each flow channel of the plurality of flow channels coupled with the inflow port and an outflow port of the plurality of outflow ports. There is a perfusion chamber formed in each of the flow channels of the plurality of flow channels, and at least a portion of each perfusion chamber is in the first member and the second member. The portions of each perfusion chamber in the first member and the second member enclose a volume when the first member is in the first position with respect to the second member. There is also a plurality of loading channels in the first member, each of the loading channels of the plurality of loading channels corresponding to the perfusion chamber in each of the flow channels, the loading channels for coupling with the portion of each perfusion chamber in the second member, when the first member is in the second position with respect to the second member.
Another embodiment of the disclosed subject matter is directed to a method of material analysis, for example, analysis of cells. The method is such that there is provided an apparatus including, at least a first member and a second member movable with respect to each other, at least one inflow port, and at least one outflow port. There is at least one flow channel in operatively coupled with the at least one inflow port and the at least one outflow port. There is at least one perfusion chamber in the at least one flow channel, with at least a portion of the at least one perfusion chamber in the first member and at least one portion of the at least one perfusion chamber in the second member. There is also at least one loading channel at least in the first member corresponding to the at least one perfusion chamber. The first member and the second member are movable with respect to each other between at least a first position and a second position. The first position is such that the at least one perfusion chamber is formed by the portions of the at least one perfusion chamber in the first member and the second member being in an operative coupling, for example, alignment, with each other so as to enclose a volume. The second position is such that the at least one loading channel is operatively coupled, for example, aligned, with the portion of the at least one perfusion chamber in the second member.
The first member and the second member are then moved to the second position, and material, for example, cells in culture media (cells) are loaded into the perfusion chamber. Once the cells have been loaded, the first member and the second member are moved to the first position, such that the material, for example, the cells, are enclosed in the volume of the at least one perfusion chamber. Perfusion media is then moved through the at least one flow channel, including the at least one perfusion chamber, to perfuse the material, for example, the cells, in the perfusion chamber. Movement or perfusion of the perfusion media is in the direction from the inflow port and out of the apparatus through the outflow port. Optical analysis may be performed on the cells in the perfusion chamber and oxygen measurements, for example, oxygen concentration measurements may be made of the perfusion media at various points along its flow path through the apparatus.
Attention is now directed to the drawing figures, where corresponding or like numerals or characters indicate corresponding or like components. In the drawings:
In this document, references are made to directions, such as upper, lower, top, bottom, up, down, upward, downward, front, rear, forward, backward, upstream, downstream, etc. These directional references are exemplary, to show the disclosed subject matter in an example orientation, and are in no way limiting.
Flow channels 40a-40h (
The inflow port 45 and outflow ports 46a-46h are, for example, hose barbs 45′, 46a′-46h′ or compression fittings. By being in this configuration, hose lines, tubing 123 (
Perfusion chambers 50a-50h (
Each perfusion chamber 50a-50h is defined by a lower frit 55 in the second piece 24 and typically an upper frit 56 in the first piece 22. The frits 55, 56 are of a porous material, such as polyethylene. The volume (when empty) or culture region (when filled with cells, cells in culture media or the like) 58 between the frits 55, 56 is where the cells in culture media are placed and remain during perfusion with perfusate, identical or similar to the culture media. The frits 55, 56 are, for example, constructed of a porous material with voids that are fine enough to prevent the cells in the culture region or volume 58 from escaping the top of the culture region 58 due to hydrodynamic pressure, or escaping through the bottom of the culture region 58 due to gravity when the flow of perfusate is stopped.
The flow channels 40a-40h, perfusion chambers 50a-50h and frits 55, 56 are typically of a cylindrical geometry. The perfusion chambers 50a-50h, may be, for example, approximately 3 mm in diameter, to be suitable for holding cells, such as Islets of Langerhans, for analysis. Other geometries such as semi-cylindrical, rectangular and square are also suitable, provided that the flow channel 40a-40h minimizes dead or unused volume.
The cells 127 in culture media in the culture region 58 (
Each perfusion chamber 50a-50h includes its own loading channel 60a-60h. Through the respective loading channel 60a-60h, cells are introduced into the volume 58 of the respective perfusion chamber 50a-50h (in the lower portion 53 of each perfusion chamber 50a-50h). The loading channels 60a-60h are formed in the first piece 22, and are positioned to align with the lower portion 53 of the respective perfusion chamber 50a-50h, when the apparatus 20 is in a loading position, as shown in
The apparatus 20 is such that each flow channel 40a-40h, and in particular, at the lower portion 53 of each perfusion chamber 50a-50h may be subjected to optical analysis, including, for example, spectral absorbance, or fluorescence. The optical analysis system includes a reflector 70 (
The optical ports 72a-72h, corresponding to the respective flow channels 40a-40h and perfusion chambers 50a-50h, are bores for receiving, for example, one or more optical fibers 154, 155 (
The fiber optics (optical fibers 154, 155 of
The apparatus 20 accommodates oxygen sensing systems for sensing inflow and outflow oxygen concentrations in the perfusion flow media. The apparatus 20 includes ports 81, 82a-82h proximate to the points of inflow and outflow of the perfusion media. The ports 81, 82a-82h (corresponding to each flow channel 40a-40h) are, for example, cylindrical bores extending from the surface of the apparatus 20. Oxygen sensors 87, 88 are placed proximate to the ports 81, 82a-82h. The oxygen sensors 87, 88 are, for example, formed of oxygen sensitive luminescent or fluorescent material.
The ports 81, 82a-82h, support optical fibers, for example, fibers 133, 138 (
The apparatus 20 supports inflow 131 and outflow 136 oxygen sensor units (
The flow channels 40a-40h at the perfusion chambers 50a-50h, are for example, of a width or diameter of approximately 1 mm to 5 mm, and a height of approximately 3 mm to 10 mm, with resulting volumes ranging from approximately 3 micro liters (μl) to 250 μl. Perfusion media flow rates through the flow channels 40a-40h may be, for example, from approximately 5 μl/min to 1000 μl/min.
Attention is now directed to
The apparatus 20 is symmetric about is longitudinal axis 25x with respect to portions of the flow channels 40a-40h, the perfusion chambers 50a-50h, loading channels 60a-60h, reflectors 70, inflow port 45 and inflow line 44a, optical 72a-72h and oxygen sensing 81, 82a-82h ports, serial line 44 and branch lines 91a-91h. Accordingly, the discussion for one example flow channel 40a and corresponding perfusion chamber 50a is applicable to all flow channels 40a-40h, perfusion chambers 50a-50h, and loading channels 60a-60h.
Turning also to
The plate 30, for example, as shown in
The plates 30, 32 and 35, of the first 22 and second 24 pieces, respectively, are made of a clear or translucent material, for example, a transparent material such as clear and transparent plastic or clear and transparent glass. This transparency supports the optical properties of the reflector 70 and corresponding optical fibers as well as the oxygen sensors 87, 88 and corresponding optical fibers of the oxygen sensor units 131, 136 (
The other plate 37 is typically also made of the same material as plates 30, 32 and 35, respectively. Alternately, this plate 37 could be made of another plastic or other material, and need not be transparent. The plates 30, 32 and 35, 37, are adhered together by adhesives, welds and other conventional fastening techniques and the plates 30, 32, 35, 37 may be made by techniques such as injection molding, or the like, if plastic, and conventional glass-making techniques, if glass.
Attention is now directed to
In
When it is desired to load the perfusion chambers 50a-50h of the apparatus 20 with cells, the upper piece 22 is moved in the direction of the arrow 126, to move from the storage position to the loading position. In an exemplary operation, just prior to moving to the loading position, the flow channels 40a-40h and perfusion chambers 50a-50h are primed with liquid, for example, perfusion media, to avoid the flow channels 40a-40h and perfusion chambers 50a-50h being exposed to air and other ambient contaminants.
Movement to the loading position is, for example, by the upper piece 22 sliding over the lower piece 24, until the loading channels 60a-60h align with lower portions 53 of the perfusion chambers 50a-50h, in order for cultured cells to be placed therein. This alignment is shown in the cross sectional view of
With the cells 127 loaded in the lower portion 53 of the respective perfusion chambers 50a-50h, the upper piece 22, is then returned to its original position (in the direction of the arrow 128). The upper 52 and lower 53 portions of the perfusion chambers 50a-50h return to being aligned, and the perfusion chambers 50a-50h are now loaded with cells 127 and sealed. The perfusion chambers 50a-50h in the apparatus 20 are now in the perfusion position, as shown in
The flow of perfusate may again be activated, so as to move through the inlet port 45, through the perfusion chambers 50a-50h, and through the respective outlet ports 46a-46h. The oxygen sensors 87, 88 are immersed in liquid (perfusion media) when the oxygen measurements are taken. Exemplary oxygen and optical measurements are shown in detail in
Returning also to
Attention is now directed to
Referring to
Alternately, only one frit 55 is necessary when the flow rate of the perfusion media is chosen to be sufficiently low, for example, approximately 1 μl/min to 25 μl/min. This low flow rate does not cause the cells in the culture region 58 to escape downstream (toward the outflow ports 46a-46e).
An inflow oxygen sensor unit 131 (shown for emphasis only in the broken line box in
Outflow oxygen sensor units 136 (shown for emphasis only in the broken line box in
The oxygen sensor units 131, 136, through their respective analytic instruments 134, measure the oxygen concentration (saturation) of the perfusion media entering (inflow unit 131) and leaving (outflow unit 136) the culture region 58. These oxygen sensor units 131, 136 are positioned in this manner, so that the oxygen concentration in the media in each perfusion chamber 50a-50h does not change due to diffusion of oxygen in or out of the cell culture media. Depending on materials used for media handling, flow rates, oxygen saturation and temperature, the amount of oxygen adsorption or desorption from materials carrying the media will change, and the necessary distance from the oxygen sensor to the culture region 58 will depend on these experimental parameters. Moreover, the oxygen consumption in each of the perfusion chambers 50a-50e is a function of the difference between the oxygen concentrations measured by the inflow sensor unit 131 and the outflow sensor unit 136.
The oxygen sensors 87, 88, are, for example, luminescent sensors, also known as fluorescent sensors. Luminescent sensors have an oxygen quenchable luminescent molecule dispersed in an oxygen permeable matrix. When the luminescence molecule containing matrix is exposed to culture media, the luminescence intensity or decay lifetime is inversely proportional to the concentration of oxygen contained in that media. Luminescent oxygen sensors may be extremely small and unobtrusive. The oxygen sensors 87, 88, when luminescent sensors, reside entirely inside the flow channels 40a-40h and are interrogated from the outside of the flow channels 40a-40h with an optical fiber 133,138 or other light transceiver. The optical fibers 133, 138 or other light transceiver, transmit and receive light from the oxygen sensors 87, 88 and the analytic instrument 134.
The analytic instruments 134 are programmed to determine, for example, oxygen concentrations, levels, amounts, etc. Alternately, the instruments 134 may be linked (electronically) to a computer (not shown) to perform the aforementioned functions.
Additional suitable exemplary oxygen sensor units are described, for example, in Sweet et al., “Continuous Measurement of Oxygen Consumption by Pancreatic Islets”, in Diabetes Technology & Therapeutics, Vol. 4, No. 5, pp. 661-672 (2002), and Wolfbeis, “Materials for Fluorescence-Based Chemical Sensors,” Journal of Material Chemistry, Vol. 15, pp. 2657-2669 (2005), both of these documents are incorporated by reference herein. Commercially available oxygen sensor units, such as the MFPF 100 from TauTheta Instruments, LLC, Boulder, Colo. 80301, USA, are also suitable.
An optical interface at or proximate to the culture region 58 serves to measure absorbance and fluorescence properties of the cultured cells 127. As also illustrated in
The optical fibers 154, 155 couple with instruments (not shown), that may be programmed to determine, for example, absorbance spectrometry, from which the state of cytochrome-c may be determined. Alternately, the instruments may be linked to a computer (not shown) to perform the aforementioned functions.
For absorbance measurements, the light source 178 functions as a broadband light source, emitting wavelengths and intensities appropriate for the intended measurement. The detector 179 is configured to record light intensity as a function of wavelength. For fluorescence measurements, for example, the light source 178 output wavelengths typically match the absorbance wavelengths of the compound, cell, molecule, component or compound of interest.
Depending on whether the absorbance or fluorescence of the culture region 58 is to be monitored, the detector 179 may function in a variety of modes. For absorbance or fluorescence measurements, the detector 179 records light intensity as a function of wavelength over a broad range, for example from approximately 200 nanometers (nm) to 1200 nm.
The detector 179, may be, for example, a Model 2000 fiber optic spectrometer, available from Ocean Optics Inc, Dunedin, Fla. Alternatively, a simplified detector comprising a single light sensitive element, such as a photodiode, or photomultiplier tube, could be used in conjunction with wavelength selective optical filters.
The detector 179 may be programmed to determine, for example, for absorbance or fluorescence, for example, to determine the state of cytochrome-c with absorbance, or for, example, to identify compounds, cells, molecules, components, or compounds of interest, such as NAD+ and NADH, with fluorescence. Alternately, the detector may be linked to a computer (not shown) to perform the aforementioned functions.
Alternate configurations of source branch 176 and detect branch 177 fiber optics may be used. These alternate configurations should be such that they maximize signal return and minimize complexity in a diffuse reflectance arrangement, such as that shown in
If desired, one or more optical fiber assemblies 152, 152′ may be combined in any combination. This allows for simultaneous absorbance and fluorescence measurements.
In this apparatus with the flow restrictors 190, oxygen consumption measurements are made in each perfusion chamber 50a, 50e by comparing the difference in oxygen measured at the single inflow oxygen sensor 131, and the multiple outflow oxygen sensors 136, that measure oxygen concentration in the perfusate outflow from each flow channel 40a, 40e. The inflow oxygen sensor 131 may be used provided that the flow rate of media through the two perfusion chambers 50a, 50e does not substantially differ (for example, on the order of approximately ±10%. Since inconsistencies in the flow channels 40a, 40e and in the frits 55, 56 may cause different flow rates through the perfusion chambers 50a, 50e, a flow restrictor 190, introduced before each flow channel 40a, 40e (for example, in the respective branch line 91a, 91e) of the respective perfusion chamber 50a, 50e, may be used to equalize flows through the individual flow channels 40a, 40e.
Other useful features and enhancements to the disclosed subject matter include the use of temperature regulation by placing the device in a controlled temperature bath or oven, and the monitoring of the metabolic response of cells to the addition of various kinds of media, drugs or agents that stimulate or suppress cellular function.
While preferred embodiments of the disclosed subject matter have been described, so as to enable one of skill in the art to practice the disclosed subject matter, the preceding description is intended to be exemplary only. It should not be used to limit the scope of the disclosure, which should be determined by reference to the following claims.
This patent application is related to and claims priority from commonly owned U.S. Provisional Patent Application Ser. No. 60/839,542, entitled: Metabolic Monitoring Device, filed Aug. 23, 2006, the disclosure of which is incorporated by reference herein.
This patent application and U.S. Provisional Patent Application Ser. No. 60/839,542 were made with Government Support, National Science Foundation Grant No. 0611015. The Government has certain rights in these patent applications.
Number | Date | Country | |
---|---|---|---|
60839542 | Aug 2006 | US |